Focus Partners Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-300
Closed -$234K 2266
2025
Q2
$234K Hold
300
﹤0.01% 1791
2025
Q1
$248K Sell
300
-600
-67% -$499K ﹤0.01% 1664
2024
Q4
$695K Hold
900
﹤0.01% 1187
2024
Q3
$797K Buy
+900
New +$809K ﹤0.01% 1008

Other funds holding LLY

Focus Partners Wealth's LLY Position: Q1 2026 in Review

Focus Partners Wealth increased its Eli Lilly (LLY) stake by 6.7% in Q1 2026, buying an estimated $15.1M and bringing the position to 237,125 shares worth $218M. The position accounts for 0.24% of the portfolio, ranked #91.

Focus Partners Wealth first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $237M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Focus Partners Wealth held 237,125 shares of Eli Lilly worth $218M as of Q1 2026.
  • Focus Partners Wealth bought 14,883 Eli Lilly shares in Q1 2026, an estimated $15.1M.
  • Eli Lilly made up 0.24% of Focus Partners Wealth's portfolio in Q1 2026, its #91 holding.
  • Focus Partners Wealth first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • Focus Partners Wealth's Eli Lilly position peaked at $237M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Focus Partners Wealth's 13F filing for Q1 2026, filed 15 May 2026.